Preconception preparation of a married couple, involving the both partners, in frequent occurrences of bacterial vaginosis
Abstract
The study covered comparison of microbial composition of urogenital tract of sexual partners of females at reproductive age with recurrent bacterial vaginosis who attended gynecologist at the stage of preconception preparation, as well as assessment of the treatment efficiency using antibacterial and immunomodulating therapy, for the risk of bacterial vaginosis recurrence.
About the Authors
N. I. TapilskayaRussian Federation
M. A. Shakhova
Russian Federation
References
1. Бабанов С. А., Агаркова И. А. Клиническая фармакология препаратов интерферона и их место в терапии инфекций урогенитального тракта // Медицинский совет. 2012; 7: 31–36.
2. Прошин С. Н., Глушаков Р. И., Шабанов П. Д. и др. Значение экспрессии TLR-рецепторов для выбора фармакологической коррекции патологии шейки матки и эндометрия // Гены и клетки. 2011; 6 (1): 91–97.
3. Савичева А. М., Соколовский Е. В., Тапильская Н. И. и др. Инфекционно-воспалительные заболевания в акушерстве и гинекологии. Руководство для врачей/Под ред. Э. К. Айламазяна. М.: ГЭОТАР-Медиа, 2016. 320 с.
4. Тапильская Н. И., Карпеев С. А., Кузнецова И. В. Хронический эндометрит — субклиническое воспалительное заболевание органов малого таза // Гинекология. 2014; 16 (1): 104–109.
5. Bradshaw C. S., Brotman R. M. Making inroads into improving treatment of bacterial vaginosis — striving for long-term cure // BMC Infect Dis. 2015; 15: 292.
6. Bradshaw C. S., Sobel J. D. Current treatment of bacterial vaginosis-limitations and need for innovation // J Infect Dis. 2016; 214, Suppl 1: S. 14–20.
7. Herbst-Kralovetz M. M., Pyles R. B., Ratner A. J. et al. New systems for studying intercellular interactions in bacterial vaginosis // J Infect Dis. 2016; 214, Suppl 1: S. 6–13.
8. Martin D. H., Marrazzo J. M. The vaginal microbiome: current understanding and future directions // J Infect Dis. 2016; 214, Suppl. 1: S. 36–41.
9. Muzny C. A., Schwebke J. R. Pathogenesis of bacterial vaginosis: discussion of current hypotheses // J Infect Dis. 2016; 214, Suppl 1: S. 1–5.
10. Nobile C. J., Mitchell A. P. Microbial biofilms: e pluribus unum // CurrBiol. 2007; 17: 349–353.
11. Swidsinski A., Verstraelen H., Loening-Baucke V., Swidsinski S., Mendling W., Halwani Z. Presence of a polymicrobial endometrial biofilm in patients with bacterial vaginosis // PLoS One. 2013; 8 (1): e53997.
12. Isik G., Demirezen S., D?nmez H. G., Beksa? M. S. Bacterial vaginosis in accosiation with spontaneous abortus and recurrent pregnancy losses // J Cytol. 2016. Jul-Sep; 33 (3): 135–14.
13. Plummer E. L., Vodstrcil L. A., Danielewski J. A., Murray G. L., Fairley C. K., Garland S. M., Hocking J. S., Tabrizi S. N., Bradshaw C. S. Combined oral and topical antimicrobial therapy for malt partners of women with bacterial vaginosis: Acceptability, tolerability and impact on the genital microbiota of couples // A pilot study. 2018, Jan 2; 13 (1). P. 1–11.
Review
For citations:
Tapilskaya N.I., Shakhova M.A. Preconception preparation of a married couple, involving the both partners, in frequent occurrences of bacterial vaginosis. Lechaschi Vrach. 2018;(2):82. (In Russ.)
JATS XML


















